Lamotrigine and rash: Scratching beneath the surface

Journal of Clinical Psychiatry

Volumn 63, Issue 11, 2002, Pages 1010-1011

  Labiner, David M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DONNATAL; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN;

DRUG EFFICACY; DRUG SAFETY; EPILEPSY; HUMAN; MENTAL DISEASE; MOOD DISORDER; NOTE; PRIORITY JOURNAL; RASH; RISK ASSESSMENT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 0036854267     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n1109     Document Type: Note

References (7)

1. Matsuo F. Lamotrigine. Epilepsia 1999;40(suppl 5):S30-S36
2. Calabrese JR, Bowden CL, Sachs GS, et al, for the Lamictal 602 Study Group. A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88
3. Calabrese JR, Suppes T, Bowden CL, et al, for the Lamictal 614 Study Group. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000;61:841-850
4. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-614
5. Lamictal (lamotrigine). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 2002:1567-1574
6. Calabrese JR, Sullivan JR, Bowden CL, et al. Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management. J Clin Psychiatry 2002;63:1012-1019
7. Messenheimer JA, Tennis P. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs commonly used in Germany: Adult and pediatric incidence estimates from registry and prescription data. Neurology 2002;58:A175-A176